Halladay Benjamin — SEC Form 4 filings
SEC reporting owner CIK 1953943. 15 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-03-15 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 11 filings — 45,628 shares, $119,553 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 10,773 shares @ $3.15 ($33,989) in Esperion Therapeutics, Inc., filed 2026-06-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. (ESPR) | Chief Financial Officer | 15 | — | 11 legs · 45,628 sh · $119,553 | 10 |
Form 4 filings — Halladay Benjamin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | Esperion Therapeutics, Inc. (ESPR) | Disposition to issuer (D): 705,410 · Disposition to issuer (D): 200,000 (derivative) · Disposition to issuer (D): 213,000 (derivative) · Disposition to issuer (D): 221,270 (derivative) | EDGAR |
| 2026-06-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 10,773 @ $3.15 | EDGAR |
| 2026-03-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 6,424 @ $2.71 | EDGAR |
| 2026-03-16 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 247,430 @ $0 · Grant/award (A): 221,270 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 7,337 @ $3.67 | EDGAR |
| 2025-09-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 7,046 @ $2.81 | EDGAR |
| 2025-07-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 11 @ $1.11 | EDGAR |
| 2025-06-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 7,229 @ $1.15 | EDGAR |
| 2025-04-21 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 8 @ $0.96 | EDGAR |
| 2025-03-19 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 3,535 @ $1.48 | EDGAR |
| 2025-03-17 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 238,000 @ $0 · Grant/award (A): 213,000 (derivative) @ $0 | EDGAR |
| 2025-02-20 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 11 @ $1.86 | EDGAR |
| 2025-01-21 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 9 @ $2.27 | EDGAR |
| 2024-12-18 | 4 | Esperion Therapeutics, Inc. (ESPR) | Sale (S): 3,245 @ $2.42 | EDGAR |
| 2024-03-15 | 4 | Esperion Therapeutics, Inc. (ESPR) | Grant/award (A): 170,000 @ $0 · Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1953943 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →